Opaleye Management Inc. Q1 2018 Filing

Filed May 14, 2018

Portfolio Value

$349.7M

Holdings

38

Report Date

Q1 2018

Filing Type

13F-HR

All Holdings (38 positions)

#StockSharesValue% PortfolioType
1
AXGNAXOGEN INC
1,715,000$62.6M17.90%
2
2L9BLUEPRINT MEDICINES
600,000$55.0M15.73%
3
LOXO ONCOLOGY
179,400$20.7M5.92%
4
CDXSCODEXIS INC
1,700,600$18.7M5.35%
5
FGENEURFIBROGEN INC
360,000$16.6M4.76%
6
STRONGBRIDGE BIOPHARMA PLC
1,590,000$14.1M4.02%
7
CORIUM INTERNATIONAL INC
1,065,000$12.2M3.49%
8
AGIOAGIOS PHARMACEUTICALS
130,000$10.6M3.04%
9
FRXFENNEC PHARMACEUTICALS INC
873,000$10.6M3.02%
10
GBYSANGAMO BIOSCIENCES INC
535,000$10.2M2.91%
11
CBAYUSDCYMABAY THERAPEUTICS INC
665,000$8.6M2.47%
12
AMAG PHARMACEUTICALS INC
420,000$8.5M2.42%
13
MIRAGEN THERAPEUTICS INC
1,060,000$7.4M2.12%
14
DCPHEURDECIPHERA PHARMACEUTICALS INC
365,000$7.3M2.09%
15
OCULOCULAR THERAPEUTIX INC
1,111,000$7.2M2.07%
16
XOMAXOMA CORP DEL
320,200$6.5M1.85%
17
BIOFRONTERA AG
391,200$6.5M1.85%
18
ARDXARDELYX
1,135,600$5.7M1.64%
19
AUDENTES THERAPEUTICS INC
190,000$5.7M1.63%
20
AMRNAMARIN CORP PLC
1,745,000$5.3M1.50%
21
ABLYNX NV
90,000$4.9M1.40%
22
FOAMIX PHARMACEUTICALS LTD
950,000$4.9M1.39%
23
VKTXVIKING THERAPEUTICS INC
1,100,800$4.8M1.38%
24
RAREULTRAGENYX PHARMACEUTICALS INC
80,000$4.1M1.17%
25
ACHILLION PHARMACEUTICALS INC
1,095,100$4.1M1.16%
26
DEPOMED INC
600,000$4.0M1.13%
27
PTCTPTC THERAPEUTICS INC
145,000$3.9M1.12%
28
TGTXTG THERAPEUTICS INC
274,200$3.9M1.11%
29
SNDXSYNDAX PHARMACEUTICALS INC
222,500$3.2M0.91%
30
CMRXEURCHIMERIX INC
600,000$3.1M0.89%
31
QTRXQUANTERIX CORP
150,000$2.6M0.73%
32
PROTALIX BIOTHERAPEUTICS INC
3,260,000$1.8M0.50%
33
FORTRESS BIOTECH INC
315,000$1.4M0.41%
34
EPIZYME INC
70,000$1.2M0.36%
35
SYROS PHARMACEUTICALS INC
74,074$961K0.27%
36
ZOSANO PHARMA CORP
100,000$504K0.14%
37
QUOTIENT LTD
60,000$282K0.08%
38
BIOLINERX LTD
250,000$214K0.06%